Prevention of venous thromboembolism

WH Geerts, JA Heit, GP Clagett, GF Pineo, CW Colwell… - Chest, 2001 - journal.chestnet.org
• Design: either prospective cohort studies or control groups of randomized trials•
Interventions: no prophylaxis used

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

WH Geerts, GF Pineo, JA Heit, D Bergqvist, MR Lassen… - Chest, 2004 - Elsevier
This article discusses the prevention of venous thromboembolism (VTE) and is part of the
Seventh American College of Chest Physicians Conference on Antithrombotic and …

Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review

RD Hull, GF Pineo, PD Stein, AF Mah… - Annals of internal …, 2001 - acpjournals.org
Purpose: Evidence-based medicine guidelines based on venographic end points recommend
in-hospital prophylaxis with low-molecular-weight heparin (LMWH) in patients having …

Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines

WH Geerts, D Bergqvist, GF Pineo, JA Heit… - Chest, 2008 - Elsevier
This article discusses the prevention of venous thromboembolism (VTE) and is part of the
Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-…

[HTML][HTML] A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients

…, RD Hull, RF Brant, L Knox, GF Pineo… - … England Journal of …, 2003 - Mass Medical Soc
Background Some observational studies suggest that the use of pulmonary-artery catheters
to guide therapy is associated with increased mortality. Methods We performed a …

[HTML][HTML] Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

RD Hull, GE Raskob, GF Pineo, D Green… - … England Journal of …, 1992 - Mass Medical Soc
Background. Low-molecular-weight heparin has a high bioavailability and a prolonged half-life
in comparison with conventional unfractionated heparin. Limited data are available for …

Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer

RD Hull, GF Pineo, RF Brant, AF Mah, N Burke… - The American journal of …, 2006 - Elsevier
PURPOSE: A substantial clinical need exists for an alternative to vitamin K antagonists for
treating deep-vein thrombosis in cancer patients who are at high risk of both recurrent venous …

The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an …

…, AA Gabbai, CS Kase, W O'Riordan, GF Pineo - The Lancet, 2007 - thelancet.com
Background Venous thromboembolism prophylaxis with low molecular weight heparin or
unfractionated heparin is recommended in acute ischaemic stroke, but which regimen provides …

[PDF][PDF] Prevention of venous thromboembolism

WH Geerts, D Bergqvist, GF Pineo, JA Heit… - Chest, 2008 - nnt.pharm.su.ac.th
This article discusses the prevention of venous thromboembolism (VTE) and is part of the
Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-…

Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada

SR Kahn, A Panju, W Geerts, GF Pineo, L Desjardins… - Thrombosis research, 2007 - Elsevier
BACKGROUND: Venous thromboembolism (VTE) prophylaxis in acutely ill medical patients
has been shown to be safe and effective. Underutilization of this patient safety practice may …